BACKGROUNDS: Cancer progression has been associated with host hemostasis system. Whether preoperative plasma hemostasis factors can predict survival in colorectal cancer is quite intriguing.
METHODS: We conducted a prospective cohort study to validate the prognostic significance of three hemostasis parameters - fibrinogen, fibrin degradation products (FDPs) and D-dimer - in non-metastatic colorectal cancer patients treated with curative resection.
RESULTS: All three parameters were positively correlated with C reactive protein(CRP) levels and Glasgow Prognostic scores (GPS). In univariate cox hazards regression model, as continuous variables, both fibrinogen (HR: 1.07, 95%CI: 1.01-1.13) and FDPs (HR: 1.17, 95%CI: 1.05-1.31) were prognostic, while D-dimer levels were not. Patients with hyperfibrinogenemia had a 2.12-fold increased mortality risk compared with patients without hyperfibrinogenemia. Patients with positive FDPs had a 3.68-fold increased mortality risk compared with patients with negative FDPs. In multivariate models, hyperfibrinogenemia was prognostic (HR: 3.39, 95%CI: 1.34-8.67) in patients with normal GPS scores.
CONCLUSIONS: Preoperative fibrinogen levels appeared as an independent mortality risk factor in non-metastatic colorectal cancer patients with normal GPS scores. Fibrinogen could be a reliable marker to identify high risk patients for those without systematic inflammation responses.
StatonCA, BrownNJ, LewisCE. The role of fibrinogen and related fragments in tumour angiogenesis and metastasis. Expert Opin Biol Ther2003; 3: 1105-1120.
2.
MartinoMM, BriquezPS, RangaA et al. Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proc Natl Acad Sci U S A2013; 110: 4563-4568.
3.
Simpson-HaidarisPJ, RybarczykB. Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein. Ann N Y Acad Sci2001; 936: 406-425.
4.
ZhengS, ShenJ, JiaoY et al. Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity. Cancer Sci2009; 100: 859-865.
5.
DavalosD, AkassoglouK. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol2012; 34: 43-62.
6.
AbshireTC, GoldSH, OdomLF et al. The coagulopathy of childhood leukemia. Thrombin activation or primary fibrinolysis? Cancer1990; 66: 716-721.
7.
PerisanidisC, PsyrriA, CohenEE et al. Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis. Cancer Treat Rev2015; 41: 960-970.
8.
PichlerM, HuttererGC, StojakovicT et al. High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients. Br J Cancer2013.
9.
PichlerM, DalpiazO, EhrlichGC et al. Validation of the preoperative plasma fibrinogen level as a prognostic factor in a European cohort of patients with localized upper tract urothelial carcinoma. J Urol2014; 191: 920-925.
10.
PedrazzaniC, CerulloG, MarrelliD et al. Is circulating D-dimer level a better prognostic indicator than CEA in resectable colorectal cancer? Our experience on 199 cases. Int J Biol Markers2010; 25: 171-176.
11.
SonHJ, ParkJW, ChangHJ et al. Preoperative Plasma Hyperfibrinogenemia is Predictive of Poor Prognosis in Patients with Nonmetastatic Colon Cancer. Ann Surg Oncol2013.
12.
YamashitaH, KitayamaJ, TaguriM, NagawaH. Effect of preoperative hyperfibrinogenemia on recurrence of colorectal cancer without a systemic inflammatory response. World J Surg2009; 33: 1298-1305.
13.
ZhuLR, LiJ, ChenP et al. Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients. Clin Transl Oncol2016; 18: 178-188.
14.
ParkBK, ParkJW, HanEC et al. Systemic inflammatory markers as prognostic factors in stage IIA colorectal cancer. J Surg Oncol2016; 114: 216-221.
15.
SilvestrisN, ScartozziM, GrazianoG et al. Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: a multicentric retrospective analysis. Expert Opin Biol Ther2015; 15: 155-162.
16.
ZhuL, LiuB, ZhaoY et al. High levels of D-dimer correlated with disease status and poor prognosis of inoperable metastatic colorectal cancer patients treated with bevacizumab. J Cancer Res Ther2014; 10 Suppl: 246-251.
17.
SunZQ, HanXN, WangHJ et al. Prognostic significance of preoperative fibrinogen in patients with colon cancer. World J Gastroenterol2014; 20: 8583-8591.
18.
MotavafE, SunesenKG, StenderMT, Thorlacius-UssingO. Prognostic value of preoperative D-dimer and carcinoembryonic antigen levels in patients undergoing intended curative resection for colorectal cancer: a prospective cohort study. Int J Colorectal Dis2014; 29: 1427-1432.
19.
LuK, ZhuY, ShengL et al. Serum fibrinogen level predicts the therapeutic response and prognosis in patients with locally advanced rectal cancer. Hepatogastroenterology2011; 58: 1507-1510.
20.
InancM, ErO, KaracaH et al. D-dimer is a marker of response to chemotherapy in patients with metastatic colorectal cancer. J Buon2013; 18: 391-397.
21.
YasudaK, SunamiE, KawaiK et al. Laboratory blood data have a significant impact on tumor response and outcome in preoperative chemoradiotherapy for advanced rectal cancer. J Gastrointest Cancer2012; 43: 236-243.
22.
KawaiK, KitayamaJ, TsunoNH et al. Hyperfibrinogenemia after preoperative chemoradiotherapy predicts poor response and poor prognosis in rectal cancer. Int J Colorectal Dis2011; 26: 45-51.
23.
OyaM, AkiyamaY, OkuyamaT, IshikawaH. High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer. Jpn J Clin Oncol2001; 31: 388-394.
24.
TangL, LiuK, WangJ et al. High preoperative plasma fibrinogen levels are associated with distant metastases and impaired prognosis after curative resection in patients with colorectal cancer. J Surg Oncol2010; 102: 428-432.
25.
ZemanM, MaciejewskiA, PoltorakS, KryjM. Evaluation of outcomes and treatment safety of patients with metastatic colorectal cancer to the liver with estimation of prognostic factors. Pol Przegl Chir2014; 85: 333-339.
26.
YamamotoM, YoshinagaK, MatsuyamaA et al. Plasma D-dimer level as a mortality predictor in patients with advanced or recurrent colorectal cancer. Oncology2012; 83: 10-15.
27.
KilicM, YoldasO, KeskekM et al. Prognostic value of plasma D-dimer levels in patients with colorectal cancer. Colorectal Dis2008; 10: 238-241.
28.
DejanaE, LanguinoLR, PolentaruttiN et al. Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. J Clin Invest1985; 75: 11-18.
29.
SahniA, Simpson-HaidarisPJ, SahniSK et al. Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). J Thromb Haemost2008; 6: 176-183.
30.
ShuYJ, WengH, BaoRF et al. Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study. BMC Cancer2014; 14: 566.
31.
RocheY, PasquierD, RambeaudJJ et al. Fibrinogen mediates bladder cancer cell migration in an ICAM-1-dependent pathway. Thromb Haemost2003; 89: 1089-1097.
32.
SahniA, ArevaloMT, SahniSK, Simpson-HaidarisPJ. The VE-cadherin binding domain of fibrinogen induces endothelial barrier permeability and enhances transendothelial migration of malignant breast epithelial cells. Int J Cancer2009; 125: 577-584.
33.
VerheulHM, van ErpK, HomsMY et al. The relationship of vascular endothelial growth factor and coagulation factor (fibrin and fibrinogen) expression in clear cell renal cell carcinoma. Urology2010; 75: 608-614.
34.
PalumboJS, PotterJM, KaplanLS et al. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res2002; 62: 6966-6972.
35.
PalumboJS, KombrinckKW, DrewAF et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood2000; 96: 3302-3309.
36.
AlvesCS, KonstantopoulosK. PDGF suppresses the sulfation of CD44v and potentiates CD44v-mediated binding of colon carcinoma cells to fibrin under flow. PLoS One2012; 7: e41472.
37.
PalumboJS, TalmageKE, MassariJV et al. Platelets and fibrin (ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood2005; 105: 178-185.
38.
RybarczykBJ, Simpson-HaidarisPJ. Fibrinogen assembly, secretion, and deposition into extracellular matrix by MCF-7 human breast carcinoma cells. Cancer Res2000; 60: 2033-2039.
39.
WojtukiewiczMZ, ZacharskiLR, MemoliVA et al. Indirect activation of blood coagulation in colon cancer. Thromb Haemost1989; 62: 1062-1066.
40.
CostantiniV, ZacharskiLR, MemoliVA et al. Fibrinogen deposition without thrombin generation in primary human breast cancer tissue. Cancer Res1991; 51: 349-353.
